Dr. Ansell on Recent Therapeutic Advancements in MCL

Video

In Partnership With:

Stephen M. Ansell, MD, PhD, professor of medicine, Mayo Clinic, discusses some of the recent therapeutic advancements that have been reported in the field of mantle cell lymphoma (MCL).

Stephen M. Ansell, MD, PhD, professor of medicine, Mayo Clinic, discusses some of the recent therapeutic advancements that have been reported in the field of mantle cell lymphoma (MCL).

MCL is a disease that is moving and changing rapidly, Ansell explains. Some of the more standard approaches, he adds, are now being challenged by novel combinations and therapies. Previously, physicians took the approach that patients who were young and healthy were given a more aggressive chemotherapy treatment followed by stem cell transplantation, whereas elderly patients were treated with a more palliative regimen.

However, some of these newer agents, such as lenalidomide (Revlimid) and ibrutinib (Imbruvica), in combination with antibodies have resulted in excellent results. For the future, Ansell says the community will begin to see some of these new combinations being tested against more of the standard therapies. This will lead to a more sophisticated and nuanced treatment, rather than a very aggressive, nonpersonalized approach.

Related Videos
Christian Marth, MD, PhD, head, professor, Department of Obstetrics and Gynecology, Innsbruck Medical University
Mansoor Raza Mirza, MD, chief oncologist, Department of Oncology, Rigshospitalet, Copenhagen University Hospital
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology
Dimitrios Nasioudis, MD, fellow, Gynecologic Oncology, Perelman School of Medicine, the University of Pennsylvania
Sara Corvigno, MD, PhD, translational researcher, oncology, The University of Texas MD Anderson Cancer Center
I-Chia (Daniel) Liu, MD
Robert W. Mutter, MD
Saad J. Kenderian, MB, CHB, consultant, Division of Hematology, Department of Internal Medicine, Department of Immunology, Department of Molecular Medicine, assistant professor, oncology, immunology, medicine, Mayo Clinic
Mary-Ellen Taplin, MD